Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-03-05 2019-03-04
Drug Identification Number 02375885 02375885
Brand name APPRILON APPRILON
Common or Proper name Doxycycline Monohydrate Doxycycline Monohydrate
Company Name GALDERMA CANADA INC GALDERMA CANADA INC
Ingredients DOXYCYCLINE DOXYCYCLINE
Strength(s) 40MG 40MG
Dosage form(s) CAPSULE (IMMEDIATE AND DELAYED RELEASE) CAPSULE (IMMEDIATE AND DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 14 capsule blister cards in a carton of 2 cards (28 capsules) 14 capsule blister cards in a carton of 2 cards (28 capsules)
ATC code J01AA J01AA
ATC description TETRACYCLINES TETRACYCLINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-01-14 2019-01-14
Estimated end date 2019-03-04 2019-03-04
Actual end date 2019-03-04 2019-03-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments